NCT07207395
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07207395
Title A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Christ Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.